NIH Insiders Hopeful That New Measures Will Improve Intramural Research Efforts

Intramural Research Efforts Author: FRANKLIN HOKE, pp.1 Date: May 30,1994 Influence of the agency's scientific directors will ebb if NIH adopts revised methods of reviewing quality, approving tenure Scientists and administrators at the National Institutes of Health are optimistic that changes suggested by an external advisory committee in a recent report will prove effective in strengthening the agency's intramural research prog

Written byFranklin Hoke
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Intramural Research Efforts Author: FRANKLIN HOKE, pp.1
Date: May 30,1994

Influence of the agency's scientific directors will ebb if NIH adopts revised methods of reviewing quality, approving tenure

Scientists and administrators at the National Institutes of Health are optimistic that changes suggested by an external advisory committee in a recent report will prove effective in strengthening the agency's intramural research program.

The program, seen by various observers to be slipping in quality in recent years, involves some 6,000 NIH scientists and postdoctoral trainees, with support of their efforts accounting for about 11 percent of NIH's $11 billion budget.

By contrast, about 80 percent of the agency's money goes to its extramural program, in which tens of thousands of scientists in university laboratories and other research settings across the United States compete for comparatively scarce support.

Increasingly, extramural research proposals judged by peer review to be "very good" or even "excellent" ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies